SCHEMBL5794072

SCHEMBL5794072

CCc1nn(CC(=O)O)c(SCc2nc3ccccc3[nH]2)nc1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 1/20 0.48
▸ PDE1B Q01064 1/20 0.48
▸ PDE4D Q08499 1/20 0.48
▸ PDE3A Q14432 1/20 0.48
▸ PDE7B Q9NP56 1/20 0.48
▸ PDE10A Q9Y233 1/20 0.48
▸ SMN1; SMN2 Q16637 5/20 0.47
▸ CYP1A2 P05177 3/20 0.47
▸ CYP2C9 P11712 3/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ CYP2D6 P10635 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ THRB P10828 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.44
▸ MAPK1 P28482 3/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6112072 0.74 MEN1 (0.45) CYP3A4CYP2D6HPGDALDH1A1LMNA
SCHEMBL5794763 0.72 PTGDR2 (0.53) SMN1; SMN2NPC1RAB9AHSD17B10HPGD
SCHEMBL5793463 0.71 ALDH1A1 (0.41) SMN1; SMN2RAB9AHSD17B10HPGDALDH1A1
SCHEMBL5793255 0.69 DAO (0.42) CYP3A4CYP2D6LMNAPTGDR2ALOX15
SCHEMBL5792610 0.69 PTGDR2 (0.36) CYP3A4CYP2D6LMNAPTGDR2ALOX15
SCHEMBL7823940 0.67 SMN1; SMN2 (0.66) SMN1; SMN2CYP1A2CYP2C9NPC1RAB9A
SCHEMBL3429462 0.66 SMN1; SMN2 (1.00) SMN1; SMN2CYP1A2CYP2C9NPC1RAB9A
SCHEMBL9671660 0.66 PDE7A (0.67) PDE5APDE1BPDE4DPDE3APDE7B
SCHEMBL11130494 0.66 NPC1 (0.65) SMN1; SMN2CYP1A2CYP2C9NPC1RAB9A
SCHEMBL6112515 0.65 ALOX15 (0.52) CYP1A2CYP2C9CYP3A4CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644353-A1 AMIDE-SUBSTITUTED 1,2,4-TRIAZIN-5(2H)-ONES FOR THE TREATMENT OF CHRONICALLY INFLAMMATORY DISEASES Bayer HealthCare AG (DE) 2006-04-12 — — EP disclosed
WO-2005003118-A1 AMIDE-SUBSTITUTED 1,2,4-TRIAZIN-5(2H)-ONES FOR THE TREATMENT OF CHRONICALLY INFLAMMATORY DISEASES BAYER HEALTHCARE AG (DE) 2005-01-13 — — WO disclosed
Send feedback